Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nang Kuang Pharmaceutical CoTPE:1752 -1.10%88 PEG Ratio is 5.23 as of Jul. 15, 2026, which is 14% below its 10-year median of 6.10. GuruFocus rates TPE:1752 with a GF Score™ of 88/100 and a GF Value™ of NT$46.62 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 209 Medical Devices & Instruments companies, Nang Kuang Pharmaceutical Co ranks worse than 83.25% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Nang Kuang Pharmaceutical Co's PEG Ratio or its related term are showing as below:
TPE:1752'
s PEG Ratio Range Over the Past 10 Years
Min: 1.04 Med: 6.1 Max: 103.27
Current: 5.22
During the past 13 years, Nang Kuang Pharmaceutical Co's highest PEG Ratio was 103.27. The lowest was 1.04. And the median was 6.10.
TPE:1752's PEG Ratio is ranked worse than 83.25% of 209
companies
in the Medical Devices & Instruments industry
Industry Median: 1.96
vs TPE:1752: 5.22
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Nang Kuang Pharmaceutical Co (TPE:1752) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Nang Kuang Pharmaceutical Co PEG Ratio Related Terms
Nang Kuang Pharmaceutical Co PEG Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Nang Kuang Pharmaceutical Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nang Kuang Pharmaceutical Co PEG Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nang Kuang Pharmaceutical Co's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Nang Kuang Pharmaceutical Co's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Nang Kuang Pharmaceutical Co (TPE:1752) has a PEG Ratio of 5.23 as of Jul. 15, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Nang Kuang Pharmaceutical Co and its competitors. This is 14% below median its historical median of 6.10. Over the past decade, Nang Kuang Pharmaceutical Co's PEG Ratio has ranged from 1.04 to 103.27. According to the industry distribution chart, Nang Kuang Pharmaceutical Co ranks #174 out of 209 companies in the Medical Devices & Instruments industry, placing it in the top 83.3%.
Is Nang Kuang Pharmaceutical Co's PEG Ratio too high?
Nang Kuang Pharmaceutical Co's current PEG Ratio of 5.23 is 14% below median its 10-year median of 6.10. Over the past 10 years, this metric has ranged from a low of 1.04 to a high of 103.27. The Medical Devices & Instruments industry median PEG Ratio is 1.96. Nang Kuang Pharmaceutical Co's value of 5.23 is 166.8% above this industry median. Based on the distribution chart, Nang Kuang Pharmaceutical Co ranks #174 out of 209 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Nang Kuang Pharmaceutical Co has a GF Score™ of 88/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nang Kuang Pharmaceutical Co's PEG Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Nang Kuang Pharmaceutical Co ranks #174 out of 209 companies for PEG Ratio. This places Nang Kuang Pharmaceutical Co in the lower half of its industry. The industry median PEG Ratio is 1.96. Nang Kuang Pharmaceutical Co's value of 5.23 is 166.8% above this benchmark. Historically, Nang Kuang Pharmaceutical Co's own PEG Ratio has ranged from 1.04 to 103.27 over the past decade. While the company's 10-year median is 6.10 vs. the industry median of 1.96, Nang Kuang Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Devices & Instruments company?
The median PEG Ratio among Medical Devices & Instruments companies is 1.96, based on 209 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nang Kuang Pharmaceutical Co's current PEG Ratio of 5.23 is 166.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Nang Kuang Pharmaceutical Co and its competitors. For the Medical Devices & Instruments industry, the median PEG Ratio is 1.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nang Kuang Pharmaceutical Co's current PEG Ratio is 5.23, which is 14% below median its own 10-year median of 6.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nang Kuang Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Nang Kuang Pharmaceutical Co (TPE:1752) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$46.62, compared to a current price of NT$31.35 — trading 32.8% below its estimated fair value. The current PEG Ratio is 5.23, which is 14% below median its 10-year median of 6.10 and 166.8% above the Medical Devices & Instruments industry median of 1.96. Nang Kuang Pharmaceutical Co's overall GF Score™ is 88/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Nang Kuang Pharmaceutical Co (TPE:1752), the current PEG Ratio is 5.23 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nang Kuang Pharmaceutical Co (TPE:1752) Overvalued in 2026?
Based on GuruFocus' analysis, Nang Kuang Pharmaceutical Co stock appears to be undervalued.
The current stock price of NT$31.35 is trading 32.8% below its estimated GF Value™ of NT$46.62.
GuruFocus considers Nang Kuang Pharmaceutical Co to be Significantly Undervalued.
Key valuation signals for TPE:1752:
PEG Ratio: 5.23 (14% below median its 10-year median of 6.10)
GF Value™: NT$46.62 vs. price of NT$31.35 (32.8% below fair value)
Industry Position: 166.8% above the Medical Devices & Instruments median (#174 of 209)
No single metric tells the full story. See the TPE:1752 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nang Kuang Pharmaceutical Co Ltd is a Taiwan-based company, its subsidiaries are engaged in the manufacture, processing, and trading, and import and export of pharmaceuticals and medical devices. Its products are Cardiovascular system medications, Gastrointestinal medications, Nervous system drugs, Nutrition and Metabolism, Hospital infusion solution, blood products, Anticancer immunomodulators, Musculoskeletal system, and Others. Geographically, the company operates in Taiwan, China, Japan, the USA, and Other countries.
88GF Score
Get the complete analysis for TPE:1752
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1752 has been successfully added to your 
